[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540263":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":47,"collaborators":10,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with vaginal cancer",null,"Patients affected by vaginal cancer",[13],"Radiation: Radiochemotherapy plus interventional radiotherapy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"RADIATION","Radiochemotherapy plus interventional radiotherapy","All patients with vaginal cancer will undergo radiochemotherapy (45 Gy on pelvis and tumor in association with cisplatinum) plus interventional radiotherapy (28 Gy on residual disease) with exclusive intent",[9],[21],{"name":22,"affiliation":5,"role":23},"VALENTINA LANCELLOTTA","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"VALENTINA LANCELLOTTA, MD","CONTACT","+390630155701","valentina.lancellotta@policlinicogemelli.it",[31],{"facility":32,"status":33,"city":34,"state":10,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Fondazione Policlinico Universitario A. Gemelli IRCCS","RECRUITING","Roma","00168","Italy","IT",{"type":39,"coordinates":40},"Point",[41,42],11.10642,44.99364,{"lat":42,"lon":41},[45,46],{"name":22,"role":27,"phone":28,"phoneExt":10,"email":29},{"name":22,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100540263","radiochemotherapy-and-interventional-radiotherapy-in-vaginal-cancer-100540263",false,"NCT06314568","Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer","Radiochemotherapy Treatment Followed by Interventional Radiotherapy in Patients Affected by Vagina Carcinoma Multi-centric Prospective Observational Study Trimodal Definitive Invasive Vaginal Carcinoma Treatment","TRIDENT","Inclusion Criteria:\n\n* Age more than18 years old\n* Performance status 0,1\n* Hystological diagnosis of squamous vaginal cancer\n* HPV, p16, p53 status\n* Stage I, II, III and IV (AJCC 2018th version)\n* Stadiation with magnetic resonance and positron emission tomography\n* Informed consensus\n\nExclusion Criteria:\n\n* Age inferior 18 years old\n* Performance status more than 2\n* Previous cancer in the last ten years\n* Previous radiation treatment in the region of interest\n* Presence of pathologies that contraindicate radiotherapy treatment (genetic syndromes of hyper-radiosensitivity, ulcerative colitis, diverticulitis in the acute phase, severe diverticulosis, chronic pelvic inflammation)\n* Presence of internal pathologies that contraindicate chemotherapy or radio-chemotherapy treatment (severe liver disease, heart disease, renal failure, etc.)\n* Presence of distant metastases in sites other than the pelvic lymph nodes\n* Any significant medical condition that in the opinion of the investigator may interfere with the patient's optimal participation in the study","FEMALE","18 Years",{"count":60,"type":61},278,"ESTIMATED","OBSERVATIONAL","Prospective observational multicenter study, aimed at evaluating the effectiveness on local control and cancer-specific survival of radiochemotherapy followed by interventional radiotherapy in patients affected by vaginal cancer",[65],"Vaginal Cancer","2025-08-12",{"date":68,"type":69},"2025-08-15","ACTUAL",{"date":71,"type":69},"2024-03-15",{"date":73,"type":61},"2028-12-31",{"name":5,"class":6},1]